Research and Evaluation on Drugs and Crime, FY 2019

0
241

Funding Opportunity ID: 312887
Opportunity Number: NIJ-2019-15444
Opportunity Title: Research and Evaluation on Drugs and Crime, FY 2019
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Law, Justice and Legal Services
Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s): 16.560
Eligible Applicants: State governments
County governments
City or township governments
Special district governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Individuals
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: See full announcement for complete eligibility information.
Agency Code: USDOJ-OJP-NIJ
Agency Name: Department of Justice
National Institute of Justice
Posted Date: Feb 14, 2019
Close Date: May 06, 2019
Last Updated Date: Feb 14, 2019
Award Ceiling: $3,000,000
Award Floor: $0
Estimated Total Program Funding: $3,000,000
Expected Number of Awards: 5
Description: NIJ supports rigorous applied research on evidence-based tools, protocols, and policies for State, tribal, and local law enforcement and other criminal justice agencies that address drug trafficking, drug markets, and drug-related violence. The research focus of this solicitation is criminal investigation, prosecution, drug intelligence, and community surveillance relevant to narcotics law enforcement, forensic science, and/or medicolegal death investigation. DOJ has identified the FY2019 solicitation drug priorities as: 1) fentanyl and its illicit analogues, 2) methamphetamine, and 3) illegal marijuana markets.
Version: 1





Visit the Official Webpage For More Details on Research and Evaluation on Drugs and Crime, FY 2019

LEAVE A REPLY

Please enter your comment!
Please enter your name here